Site-selective 8-chloro-cyclic adenosine 3',5'-monophosphate as a biologic modulator of cancer: restoration of normal control mechanisms.
Cho-Chung
Y S
YS
Cellular Biochemistry Section, Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, MD 20892.
D015124:8-Bromo Cyclic Adenosine Monophosphate / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000241:Adenosine / Q000031:analogs & derivatives; D000970:Antineoplastic Agents; D002454:Cell Differentiation / Q000187:drug effects; D005786:Gene Expression Regulation / Q000187:drug effects; D006131:Growth Inhibitors; D006801:Humans; D066298:In Vitro Techniques; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009687:Nuclear Proteins / Q000502:physiology; D011953:Receptors, Cyclic AMP / Q000502:physiology; D014157:Transcription Factors / Q000502:physiology; D015291:Transforming Growth Factors / Q000037:antagonists & inhibitors; D014407:Tumor Cells, Cultured / Q000187:drug effects* / Q000648:ultrastructure
D000970:Antineoplastic Agents; D006131:Growth Inhibitors; D009687:Nuclear Proteins; D011953:Receptors, Cyclic AMP; D014157:Transcription Factors; D015124:8-Bromo Cyclic Adenosine Monophosphate; D015291:Transforming Growth Factors; C044258:8-chloro-cyclic adenosine monophosphate; D000241:Adenosine